SNOMED CT Concept  138875005

Clinical finding  404684003

Disease  64572001

Adverse reactions  281647001

Adverse reaction to drug  62014003

Drug groups primarily affecting musculoskeletal system adverse reaction  292670005

Adverse reaction to non-steroidal anti-inflammatory drug  292068000

Fenbufen adverse reaction   292074000

SNOMED CT code


SNOMED code292074000
nameFenbufen adverse reaction
statusremoved
date introduced2002-01-31
date removed2004-07-31
fully specified name(s)Fenbufen adverse reaction (disorder)
synonymsFenbufen adverse reaction
parentsAdverse reaction to non-steroidal anti-inflammatory drug   292068000  removed: 2006-01-31
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Clinical finding   404684003
    Disease   64572001
      Adverse reactions   281647001
        Adverse reaction to drug   62014003
          Drug groups primarily affecting musculoskeletal system adverse reaction   292670005  removed: 2020-07-31
            Adverse reaction to non-steroidal anti-inflammatory drug   292068000  removed: 2006-01-31
              Fenbufen adverse reaction   292074000  removed: 2004-07-31

ancestors
sorted most to least specific
  • Adverse reaction to non-steroidal anti-inflammatory drug   292068000  removed: 2006-01-31
  • Drug groups primarily affecting musculoskeletal system adverse reaction   292670005  removed: 2020-07-31
  • Adverse reaction to drug   62014003
  • Adverse reactions   281647001
  • Disease   64572001
  • Clinical finding   404684003
  • SNOMED CT Concept   138875005
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.